Biolimus-eluting biodegradable polymer-coated stent versus bare metal stent in acute ST-elevation and non-ST elevation myocardial infarction: Justification for biodegradable polymer-coated stent in acute coronary syndrome (JANICE) registry

References

• Bavry AA, Kumbhani DJ, Quiroz R, . Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: A meta-analysis and review of the literature. Am J Cardiol. 2004;93:830–5.
   PubMed Web of Science ®Google Scholar
• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13–20.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Cannon CP, Fox KA, . Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908–17.
   PubMed Web of Science ®Google Scholar
• Meier P, Zbinden R, Togni M, . Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol. 2007;49:15–20.
   PubMed Web of Science ®Google Scholar
• Nebeker JR, Virmani R, Bennett CL, . Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol. 2006;47:175–81.
   PubMed Web of Science ®Google Scholar
• Togni M, Windecker S, Cocchia R, . Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol. 2005;46:231–6.
   PubMed Web of Science ®Google Scholar
• Azarbal B, Currier JW. Allergic reactions after the implantation of drug-eluting stents: Is it the pill or the polymer? J Am Coll Cardiol. 2006;47:182–3.
   Google Scholar
• Virmani R, Guagliumi G, Farb A, . Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004;109:701–5.
   PubMed Web of Science ®Google Scholar
• McFadden EP, Stabile E, Regar E, . Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519–21.
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Finn AV, Joner M, . Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008;118:1138–45.
   PubMed Web of Science ®Google Scholar
• Urban P, Gershlick AH, Guagliumi G, ; e-Cypher investigators. Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-Cypher registry. Circulation 2006;113:1434–41.
   PubMed Web of Science ®Google Scholar
• de la Torre-Hernández JM, Alfonso F, Hernández F ; ESTROFA Study Group. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (estudio ESpanol sobre trombosis de stents farmacoactivos). J Am Coll Cardiol. 2008;51:986–90.
   PubMed Web of Science ®Google Scholar
• Daemen J, Wenaweser P, Tsuchida K, . Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667–78.
   PubMed Web of Science ®Google Scholar
• Park DW, Park SW, Park KH, . Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol. 2006;98:352–6.
   PubMed Web of Science ®Google Scholar
• Steg PG, Fox KA, Eagle KA, .; Global Registry of Acute Coronary Events (GRACE) Investigators. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the global registry of acute coronary events. Eur Heart J. 2009;30:321–9.
   PubMed Web of Science ®Google Scholar
• Prineas R, Crow R, Blackburn H. The Minnesota code manual of electrocardiographic findings. Littleton, MA: John Wright-PSG; 1982.
   Google Scholar
• Cutlip DE, Windecker S, Mehran R, . Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344–51.
   PubMed Web of Science ®Google Scholar
• Grube E, Buellesfeld L. BioMatrix biolimus A9-eluting coronary stent: A next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 2006;3:731–41.
   PubMed Web of Science ®Google Scholar
• Grube E, Hauptmann K, Buellesfeld L, . Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating. EuroIntervention 2005;1:53–7.
   PubMedGoogle Scholar
• Chevalier B, Serruys PW, Silber S, . Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial. EuroIntervention 2007;2:426–34.
   PubMedGoogle Scholar
• Chevalier B, Silber S, Park SJ, .; NOBORI 1 clinical investigators. Randomized comparison of the Nobori biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: The NOBORI 1 trial—phase 2. Circ Cardiovasc Interv. 2009;2:188–95.
   PubMed Web of Science ®Google Scholar
• Ostojic M, Sagic D, Beleslin B, . First clinical comparison of Nobori—biolimus A9 eluting stents with cypher-sirolimus eluting stents: Nobori core nine months angiographic and one year clinical outcomes. EuroIntervention 2008;3:574–9.
   PubMedGoogle Scholar
• Laarman GJ, Suttorp MJ, Dirksen MT, . Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006;55:1105–13.
   Google Scholar
• Spaulding C, Henry P, Teiger E ; TYPHOON investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;55:1093–104.
   Google Scholar
• Valgimigli M, Percoco G, Malagutti P, .; STRATEGY Investigators. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: A randomized trial. JAMA 2005;293:2109–17.
   PubMed Web of Science ®Google Scholar
• Menichelli M, Parma A, Pucci E, . Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol. 2007;49:1924–30.
   PubMed Web of Science ®Google Scholar
• Mauri L, Silbaugh TS, Garg P, . Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med. 2008; 359:1330–42.
   PubMedGoogle Scholar
• Stone GW, Lansky AJ, Pocock SJ, . Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360:1946–59.
   PubMed Web of Science ®Google Scholar
• Pasceri V, Patti G, Speciale G, . Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J. 2007;153:749–54.
   PubMed Web of Science ®Google Scholar
• Kastrati A, Dibra A, Spaulding C, . Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28: 2706–13.
   PubMed Web of Science ®Google Scholar
• De Luca G, Stone GW, Suryapranata H, . Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. Int J Cardiol. 2009;133: 213–22.
   Google Scholar
• Brar SS, Leon MB, Stone GW, . Use of drug-eluting stents in acute myocardial infarction: A systematic review and meta-analysis. J Am Coll Cardiol. 2009;53:1677–89.
   PubMedGoogle Scholar
• Lee CH, Lim J, Low A, Zhang XL, . Sirolimus-eluting, bioabsorbable polymer-coated constant stent (Cura™) in acute ST-elevation myocardial infarction: A clinical and angiographic study (CURAMI Registry). J Invasive Cardiol. 2007;19:182–5.
   PubMedGoogle Scholar
• Windecker S, Serruys PW, Wandel S, . Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial. Lancet 2008;372:1163–73.
   PubMed Web of Science ®Google Scholar
• Garg S, Sarno G, Serruys PW, . The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. Eurointervention 2010;6:233–9.
   Google Scholar